Winter 2009 - The Canadian MPS Society
Transcription
Winter 2009 - The Canadian MPS Society
Highlights in this issue: Medical Advisory Board Member Profile: Dr. Julian Raiman—page 6 Parents & patients meet in Toronto—page 11 Taiwan hosts the AsiaPacific MPS conference & symposium on rare diseases—page 20 Toronto Scotiabank Waterfront Marathon—page 24 Mark your calendars for the Society’s National Family Conference: July 23-25, 2010—page 14 Winter 2009 Happy Holidays from the Canadian MPS Society! InThis Issue Director Reports/Welcome/Membership Renewal 4 MAB Member Profile—Dr. Julian Raiman 6 Donations 7 Memorials /Birthday Greetings 8 Correspondence/Family News 10 Toronto Regional Meeting 11 Advocacy 12 Upcoming Conferences & Events 14 Research & Clinical Trials 16 2009 JAPAC Educational Forum in Taiwan 20 In the News 22 Fundraising—Toronto Waterfront Marathon 24 Fundraising—A Night of Enchantment 26 Fundraising—Walk with Nature 27 Fundraising—Hope Shines Bright Gala 28 Fundraising 29 Society Merchandise 32 Society Forms 33 Family Assistance Program Funding Application 34 Society Publications 35 Season’s Greetings/Holiday Art Contest winner 36 THE CANADIAN SOCIETY FOR MUCOPOLYSACCHARIDE & RELATED DISEASES INC. PO Box 30034, RPO Parkgate North Vancouver, BC V7H 2Y8 Tel (604) 924-5130/1-800-667-1846 Fax (604) 924-5131 kirsten@mpssociety.ca/www.mpssociety.ca Charity #12903 0409 RR0001 The Canadian MPS Society’s Mission Statement: The Canadian MPS Society is committed to: Providing support to families affected with MPS and related diseases. Educating medical professionals and the general public about MPS and related diseases. Raising funds for research so that one day there will be cures for all types of MPS and related diseases. What are MPS & Related Diseases? Lysosomal storage diseases (LSDs) are rare, progressive genetic disorders. Often, these diseases are inherited from parents who have no idea they carry the responsible recessive genes. People born with MPS and related lysosomal storage diseases cannot produce certain enzymes necessary for breaking down and recycling cells. Consequently, these cells store throughout the bodies of those with LSDs, in areas including their hearts, respiratory systems, bones, joints, and central nervous systems. Babies may show no signs of disease, but as more cells become damaged and storage increases, symptoms begin to appear. For more detailed information about individual diseases, treatments and research, please visit our website at www.mpssociety.ca or order one of our disease-specific booklets from the order form on page 35. Support for families. Research for a cure. Smiling faces on the front cover: Nathaniel Phaneuf (MPS II) and his sister Chelsea choosing their Christmas tree. “Nobody, but nobody, can make it out here alone” -Maya Angelou Page 2 Do you have family news, photos, fundraising news or an interesting article to share with the Connection’s readers? Newsletter submission deadlines: Please submit by email, if possible, to kirsten@mpssociety.ca or jill@mpssociety.ca Fall Issue: Spring Issue: Summer Issue: Winter Issue: February 1st May 1st August 1st November 1st The Connection Board of Directors and Medical Advisory Board Executive Director: Kirsten Harkins PO Box 30034, RPO Parkgate North Vancouver, BC V7H 2Y8 MPS I parent (604) 924-5130 kirsten@mpssociety.ca Jill Ley, Executive Assistant Mary Nelis, Quebec Representative Robin Casey Bedford, QC MPS I parent (450) 248-7376 mary.nelis@sympatico.ca Joe Clarke Bernie Geiss North Vancouver, BC Professional (604) 924-3451 bgeiss@shaw.ca jill@mpssociety.ca Todd Harkins Board of Directors: Judy Byrne, Chair Guelph, ON MPS I parent (519) 836-5949 judy@mpssociety.ca Carrie Nimmo, Vice—Chair Vancouver, BC MPS I aunt (604) 255-5456 carrie@mpssociety.ca Jean Linden, Secretary Prince George, BC MPS III parent (250) 564-3698 jean@mpssociety.ca Brenda MacLean, Treasurer Professional (604) 980-7556 goodtogreat758@hotmail.com Barbara Boland, Newfoundland Representative St. John’s, NFLD MPS III parent (709) 753-7874 barbara@mpssociety.ca M.D., M.S.C. Alberta Children’s Hospital Calgary, AB North Vancouver, BC MPS I parent (604) 929-8969 todd@mpssociety.ca Aubrey Hawton Moonstone, ON MPS III parent (705) 835-5288 aubrey@mpssociety.ca M.D., Ph.D. Hospital for Sick Children Toronto, ON Mark Ludman M.D., F.R.C.P.C., F.C.C.M.G. IWK Health Centre Halifax, NS Serge Melancon M.D. Montreal Children’s Hospital Montreal, QC Cheryl Rockman-Greenberg M.D., C.M., F.R.C.P. Winnipeg Children’s Hospital Winnipeg, MN Randall Linton Toronto, ON MPS III parent (416) 223-0078 randall@interiorcare.com Julian Raiman Deb Purcell Tony Rupar Vancouver, BC MPS II Parent (604) 222-2767 dcehak@telus.net M.D. CPRI London, ON M.D. Hospital for Sick Children Toronto, ON Sylvia Stockler Medical Advisory Board: M.D. BC Children’s Hospital Vancouver, BC Lorne Clarke, Chair M.D,C.M.,F.R.C.P.C.,F.C.C.M.G. University of British Columbia Vancouver, BC Accountant: Quantum Accounting, Vancouver, BC Canadian MPS Society Bank Account: TD Canada Trust Winter 2009 Page 3 Chair’s Report Season’s Greetings from the Board of the Canadian MPS Society. May the season bring you peace of mind and peace of spirit. The board is now starting to focus on our upcoming family conference in Alliston, Ontario. Please make sure to set aside July 23 to 25, 2010 and join us and other MPS families for an informative and enjoyable weekend. On October 23, 2009, I had the pleasure of attending the Emma-Rose Gala in honour of Emma-Rose GrenonLeMaitre and her family. Lara Pietrolungo, a long time friend of the LeMaitre’s and a nurse at Toronto’s Sick Kids, took it upon herself to put this gala together. It was a truly elegant evening, and all proceeds were directed to the Hospital for Sick Children in Toronto, and the family assistance programme at our Society. Many thanks to Lara and the LeMaitres for their continued support. Les membres du conseil d’administration de la Société MPS vous souhaitent leurs meilleurs voeux pour la saison des fêtes! Que la saison des fêtes vous apporte la paix et la tranquillité d’esprit. Le Conseil d’administration commence maintenant sa focalisation en vue du prochain congrès de la famille, qui aura lieu du 23 au 25 juillet 2010, à Alliston, Ontario. Prière d’inscrire ces dates à votre calendrier afin de vous joindre à nous et aux autres familles MPS, et ainsi profiter d’une fin de semaine agréable et informative. Le 23 octobre 2009, j’ai eu le plaisir d’assister au “Gala Emma Rose” dédié à rendre hommage à Emma Rose Grenon-LeMaitre et sa famille. Lara Pietrolungo qui est une amie de longue date de la famille Lemaitre et aussi une infirmière à l’hôpital Sick Kids de Toronto, a pris l’initiative d’organiser ce gala. Ce fut une soirée élégante, et toutes les recettes ont été réparties et versées à l’hôpital Sick Kids de Toronto et à notre Société, pour notre programme d’aide aux familles. Merci beaucoup à Lara et à la famille LeMaitre pour leur collaboration soutenue. All the best to everyone and I wish you a happy and healthy New Year! Judy Byrne Tous mes meilleurs voeux et bonne et heureuse année, en santé. Judy Byrne Welcome New Members: Jeremy Wighton Jeremy is the father of Abigail (MPS IH) Matthew Santos Matthew is a new adult member with MPS IVB Candice Riddell & Mike Taylor Very best wishes for a wonderful Holiday Season and a Happy Year in 2010. -Jill Ley and family Candice & Mike are the parents of Kobe (MPS II) 2010 Membership Renewals Recently, you will have received an email reminder to renew your membership for 2010 online at www.mpssociety.ca. If we do not have your email address, you’ll receive a hard copy form in January. Regardless of the time of year we receive your renewal, membership is for one calendar year only. Your renewed membership will be valid through December 31, 2010. When you renew online, you will receive a PDF income tax receipt, your membership will be updated automatically, and the Society will save on printing and postage costs. Please first login to your account, then renew your membership and update your profile so that we have your consent to include your contact information in our membership directory and to reprint your child(ren)’s photos, birthdates and/or memorial dates. Please note that your profile must be updated annually. You can find a Membership Form on page 33 if you prefer renewing the ‘old-fashioned’ way! Thank you for your continued support! Page 4 The Connection Executive Director’s Report Happy Holidays, everyone! It’s that time of year again when love, hope, joy, and generosity are most plentiful. As Oprah put it in her holiday issue of “O” magazine, “Let’s keep that giving thing going all year long!” Wouldn’t it be wonderful if we could do just that? For now, we’re hoping that our members and supporters will give thanks over the holidays for the healthy children in their lives and give generously to those children who are not as fortunate. Please contribute if you can to our Annual Fund Campaign and so that we can continue to support children, adults, and entire families affected by MPS and related diseases in 2010. In the past few months, we have been blessed by many acts of generosity and kindness—read about several fundraising events on pages 24—29. Thanks to all involved for raising awareness and funds—none of us can do this alone! One of my favourite events during the fall was our Toronto regional meeting (see page 11), as it’s so invigorating to actually see in person some of the members I correspond with throughout the year. Seeing old friends and meeting new ones made me even more excited about our national family conference, to be held this summer at the Nottawasaga Inn near Toronto. Please join us there! More details on registration will follow in our spring newsletter, and conference details will be posted on our website as planning continues. I was very fortunate to have the opportunity to travel to Asia in October (see page 20) and meet many people affected by the same issues we deal with here in Canada: Dedicated doctors, brilliant researchers, caring parents, amazing Happy Holidays from the Harkins family: children—all from very different cultures but all with the same challenges and goals as us. It was inspiring to imagine what we can do as a global team. As Todd, Kirsten, Jonas (8), Jansen (12) Helen Keller said, “Alone we can do so little; together, we can do so much.” & Nicklas (14) Wishing all of you peace and health throughout the coming year, Kirsten Harkins PLEASE SUPPORT OUR 2009 ANNUAL FUND CAMPAIGN! Enclosed with this issue of the Connection, you’ll find a letter from Candice Riddell (mother of Kobe—MPS II) describing how important the Society has been to her throughout her family’s journey with MPS. While we recognize 2009 has been a tough financial year for many Canadians, it has also been a challenging fundraising year for the Society. We rely on private donations in order to be able to continue to provide families like Candice’s—and yours—with the education, support, and hope necessary for a brighter future. We are asking our members to contribute—and encourage others to contribute as well—to the Society’s Annual Fund Campaign this holiday season. Give a gift to support those who are affected by MPS. Thank you for your support! Winter 2009 Page 5 Medical Advisory Board Member Profile Dr. Julian Raiman WHY DID YOU BECOME A DOCTOR? I wanted to be a Paediatrician, rather than a doctor per se. I would like to think it is because of a Cary Grant film I saw when he played a Paediatrician, but expect my medical family has something to do with it! WHAT LED YOU TO BECOME INVOLVED IN MPS DISEASES? After Paediatric training in England I came and did fellowship at Sick Kids under Joe Clarke, who taught me a lot about MPS diseases. He and the families at the Hospital spurred my interest. WHAT INSPIRES YOU? The parents and children I look after. TELL US A LITTLE BIT ABOUT YOUR FAMILY: I am married with two daughters aged nine and eleven. I am the youngest of six, with four sisters – so I know where I stand in the pecking order (my close family might disagree though!). PERSONAL INTERESTS/HOBBIES: Spending time with my family and an unhealthy interest in West Ham United (a struggling English soccer team). WHAT WOULD WE BE SURPIRSED TO LEARN ABOUT YOU? I was a premature baby born at 32 weeks (quite early back them!) and I directed a play at the Edinburgh Fringe Festival while at medical school – which won the award for the worst show there in 1989. Dr. Raiman speaking at our recent parent & patient meeting in Toronto about a cognition study he will be facilitating at Sick Kids. For more information on this study, please see page 19. $$ Do you know about the Canadian MPS Society’s Family Assistance Program? $$ Grants of up to $1,500.00 are available to individuals or families affected by MPS or a related disease, and can be used to offset emergency or non-emergency costs associated with care and management. Do you need a special piece of adaptive equipment that your insurance will not cover, or will only cover a portion of? Do you need home renovations to accommodate a wheelchair? View our FAP guidelines at www.mpssociety.ca under “support” and call with any questions. An application form is available for download on the website or on page 34 of the Connection. We also have Family Assistance Program funds specifically allocated for respite care. If you need a break from caring for your child(ren), we would like to help! Call for details. Page 6 The Connection Donations Todd Campbell Linda Rooney Nuha Alabssy Brenda Casselman Lisa Bernais Biomarin Pharmaceutical Inc. (Canada) Donna Rooney Harmony Rooney Shirley & Barry Bowser Tracy & Michael Davison Pierre Chayer & Christiane Parent Dennis Roth Coiffure De L'Estrie Jennifer Wren Ruth Goff Terry Turner Norman Goyette Bob Klages Margaret & Gerald Greig Jill Reekie Dorothy Harkins Steve Pendleton Frank & Verle Kaweski Dave Pal Allan & Karen Knight Maxwell Alexander Settari Fund-Calgary Patti Haney Brittany Rooney Foundation Lorene Taylor William & Louise Parker Julie Douglas-Vail Rob & Lisa Patriquin Mike Kearney Genevieve Poulin Thomas & Verna Wilcox Candice Riddell & Mike Taylor Nora Delmas Vanessa Rooney Marion Lee Ms. Esther Sherbanow Marilyn Moore Shire Human Genetic Therapies Valerie Cribbs United Way Burnaby Steve Ashley Robert & Shirley Young Rosemary Palmer MPS II Research & Time for a Cure Angela Pyatt Jeffrey Robins Donors Jen Hanbidge Tanja Balic Diane Haines Edward & Dorothy Keen Sue Cramp Henry Stulen Jill Calvert-Goetz Mary Loveday-Wight Toronto Waterfront Marathon Erica Rooney Donors Dana Rooney Bill & Jennifer Pearson Dave Stewart Dave & Sue Lambe Lindy Balasuriya David & Sonya Glass Brad Forrest Catherine & Jim Fowler Deb Ferguson Robert & Cara-Lee Moore Randy Osborn Barb Murray Paul Woolner Christine Graham Jill Robinson Ruth Henning Shelley Cornfield Nancy Fry Donna Spetko Ron McNabb Kip Barber Paul Amador Brad Toole Joan Keeling Barb Collins Donations Winter 2009 Danette Welford Terry McKauge Jim Brown Paul Lackey Cove Cliff Elementary School Jeans Day Donors Shairoz Alibhai Christy Andersen Deanna Barlow Janet Brock Christene Buchanan Theresa Lake & Christopher Burt Nina Chen Wayne Davidson Fiona Douglas-Crampton & Dan Arrigo Bob & Chris Eldon Jordyn Eyton Johan & Anna Fourie Kirsten & Robert Hannah Nicole Huth Nora Koller Ellen Leroux Ken Huckell & Joanne Maltby Matreya Monro Steve Weller & Catherine Moore Maureen Palmer Nora Pickett Colleen Quee-Newell Gil & Jessica Rosenfeld Karen & Tim Saxvik Mike & Diana Smedstad Christine Tevlin Lori Weston Emma-Rose Fund Gala Randall & Elisabeth Linton Hafiza Chiragdin Michele LaPerriere Avedis Oudabachian J.T. Watson Marie France Mistele Jessica Peterson Brenda Deseure-Casteels Mary Monty Page 7 Donations Emma-Rose Fund Gala Walk with Nature Donors Donors (cont’d) Various cash donations Martha Monty Jonathan Monty John Chesney Kim Logan Verna Maurice Bonnie Smith Gaetan Beaulieu Nancy Richard Ontario Fluid Power Ltd. Boulevard Studios Inc. Canadian Building Materials York Roofing Vera Gueorguieva Gabriel Sadaka Suzanne Lam Tim Woo Grenville Pinto Denis Geary Rachel Hostetler Dawn Irving Donna Langlois Gail Ribaux Jennifer Luce Lyne Villeneuve Karen Christiansen Pamela Bertram Daniella Bernstein France Gagne Metz Canada Ltd. Bell, Temple Great Lake Walk Donors Ken & Helga Irving In memory of Robert Johnson Peggy Johnson Esther Sherbanow Leslie & Kathleen Staley James & Dorothy Reid Marion Lamb Peter & Karen McDonald Mrs. Alva Brennan Mrs. Doris Douglas & Mrs. Carol Boyce William & Betty Porterfield Daniel & Gertrude Novak Carolyn Miller Shirley Staley Donald & Charlotte Buckle Margaret Belcher Richard Belcher Linda & Mel Tatarka John & Elda Bannon David & Henrica Maguire Stan & Louise Airdrie Robert & Patricia Johnson Ron & Cheryl Carriere Dave & Sandy Klein Tammy & Alan Jones Modern Heating Brantford Ltd. In memory of Giuseppina Sardo Vito Schiavone Carmelo & Luisa Vignanello Vincenzo & Nilla Distefano In memory of Maria Russano Rob & Lori Di Ilio In memory of Margaret Simpson Michelle Campbell-Wood In memory of Philip Bojan Dr. Joe Clarke In Honour of Matthew Di Ilio’s 19th Birthday Rob & Lori Di Ilio Remembering our Children: Bill Baillie: March 10, 1969 – January 8, 2000 — MPS II Abdullah Alglaieny: September 14, 1987 – January 15, 2008 – Fucosidosis Scott Haines: November 21, 1963 – January 27, 1991 — MPS III Jenna-Anne Woodworth: September 20, 1983 – March 11, 1989 — MPS Lindsey Olsen: April 25, 1983 – March 19, 2002 — MPS III B Jason Furoy: August 30, 1979 – March 30, 2003 — MPS I S Jamie Borys: July 30, 1993 – February 18, 2007 — MPS III A Page 88 The Connection Birthday Wishes Happy Birthday ! JANUARY Kobe Taylor – January 12, 2005 – MPS II (Hunter) Reece Polowski- January 14, 2003- MPS I-H (Hurler) Peter Bauerle – January 17, 1970 – MPS Gregory Alan Lipton – January 21, 1989 – Mucolipidosis Type IV Raza Amin- January 25, 1999- MPS III B (Sanfilippo B) FEBRUARY Sheena Hodder – February 4, 1985 – MPS IIIA (Sanfilippo A) Jean Luc Amirault - February 23, 2000 – MPS I-H (Hurler) MARCH Trey Purcell- March 1, 2004- MPS II (Hunter) Colin Collins – March 9, 1975 – MPS III A (Sanfilippo A) Andrew Lanese - March 10, 1997 – MPS II (Hunter) Sophie Marie Hamza – March 14th, 2008 – MPS IIIB (Sanfilippo B) McKay (Mac) Stiles – March 21, 2004 – MPS I-H (Hurler) Elisa Linton – March 31, 1994 – MPS III B (Sanfilippo B) We cannot print your child’s name on our Birthday list without your written consent to do so. If you would like your child’s name to appear on the Birthday list, please indicate on the current year’s Society membership form. We apologize if any names are inadvertently missed. Just give us a call and we will make sure your child’s name appears in the next edition of The Connection. Happy Birthday! Winter 2009 Page 9 Correspondence/Family News Kobe Taylor The Johnson Family (MPS I-H) (MPS II) Brantford, ON Mississauga, ON Thanks so much for your card. I’m so glad that most people contributed to MPS in Bob’s memory. I’m so glad I thought I've been meaning to call of going this route as Bob was always so good about taking me you to update you on how to see the boys even though it was a 2 -3 hour trip and visits treatment has been going short as they didn’t even know we were there. Sometimes we for Kobe. made weekend of it so Melody could enjoy a swim and fun at This Tuesday will a hotel and I could see Kevin and Scott both days. be his sixth treatment Even though he (Bob) went into hospital December 7, 2008 session and its been wonand never got back home we both knew this would be the derful. He has had no bad ending and yes, I really do miss him terribly and now that I reactions and seems to be responding to the medication well. am finally wrapping up the paper work, I find it hard to get I am very pleased and so is Mike. myself going each day after spending 9 months going to either Dr. Raiman came to see us on Monday and was very hospital or nursing home every day. happy with how well Kobe is doing. Dr. Raiman said that it Thanks again for your help and being there, and should take 8 to 12 weeks before seeing any kind of change. when I need to send a donation for someone else I will send Mike and I think some things have started to change already. it to MPS. Your sympathy cards are lovely. We go every Monday starting at 8am. Sometimes his Sincerely, infusion doesn't Peggy Johnson even start until 10am, so it’s a (Peggy’s husband Bob passed away in September 2009. Her sons very long day for Kevin and Scott had MPS III . Her daughter Melody is unaffected) Kobe and us but he is such a good boy. We try and keep him entertained for as long as possible. The first few weeks Kobe would sleep for two hours and now he stays awake but is very drowsy. I just want to thank you for all the help you gave us. I could not have gone through this without your support. I really believe in my heart that if you were not around to help Kobe he wouldn't be having his treatment. I feel like you were the only one who understood the frustration and heartache I was going through as a mother. I could thank you a billion trillion times but it will never express the gratitude I have for you and how much you mean to us. Well I've talked your ear off. Hope everything is well for you and your family. Take care talk to you soon. Candice Riddell Page 10 Melissa Bilodeau (MPS IVA) with best friend ‘Papuk’ The Connection Toronto Regional Meeting An Evening for Parents and Adult Patients affected by MPS Diseases On November 10th, close to forty people affected with or by MPS gathered in Toronto for a regional meeting hosted by the Canadian MPS Society. We were delighted to have parents of children affected by MPS I, MPS II, MPS III, MPS IV and MPS VI in attendance, as well as adults affected with MPS IV and VI—a few of whom I had never met before but got to know over the course of the evening! I was also pleased to see our charming friend David Mackay (Mannosidosis) and his parents at the meeting, and to hear about the award David won recently for his service to the Region of Durham through his volunteer work at the Fairview Lodge (see photo!). Kudos must go out to the amazing Margaret Mackrell, Ontario’s LSD coordinator at Sick Kids and nurse extraordinaire, who singlehandedly catered our dinner. The paninis were delicious! We also must thank Dr. Julian Raiman, who took time from his very busy schedule to speak to our group about the MorCAP natural history study (read more about it on page 18) and a “Caterer” Margaret Mackrell longitudinal cognition & Iffat Amin enjoy a chat study for which he will be recruiting patients in the very near future (read more about that study on page 19). Thanks, too, to Sick Kids social worker Karen Sappleton, who described a new grant program being developed for families with kids with MPS through the hospital’s Patients Amenities Program. This program will be available for families whose children are treated at Sick Kids and will be funded through money raised at the “Night of Enchantment” event, which was inspired by Emma Rose Grenon-LeMaitre (MPS I) and took place October 23rd in Toronto (see page 26). For more Winter 2009 information on this program, please email Karen at karen.sappleton@sickkids.ca. Lara Pietrolungo, a Sick Kids nurse who enthusiastically organized the fundraiser, presented me with a cheque for $5,000 toward our Family Assistance Program (FAP) just before the meeting. Kirsten with David As the Sick Mackay (Mannosidosis) Kids fund will only be available to those families who use that particular hospital, we appreciate the donation to our FAP, which of course is available to all our member families. Thanks so much for your energetic support, Lara! The evening concluded with an update on Ontario’s Rare Disease Program by Dr. Durhane Wong-Reiger, president of Canadian Organization of Rare Disorders (CORD). Durhane also filled us in on Canadian Institute of Health Research’s (CIHR’s) plan to launch a grant program specifically for rare diseases—an exciting development that we’ll keep you updated on! Thanks to Durhane for joining us, and also to Sick Kids Medical Genetics nurses Michelle Mecija and Dawn Cordeiro for being Durhane Wong-Reiger speaking such strong supporters of the families they serve. Thanks to all who made the effort to attend the Toronto regional meeting. It was so wonderful to be together with many of our Toronto-are members, and I look forward to seeing you again this summer at our National Family Conference! Kirsten Matthew Santos (MPS IVB), his girlfriend, & Verica Gacic have a visit Page 11 Advocacy ERT Funding for MPS I All individuals requiring Aldurazyme enzyme replacement therapy in Canada are being treated, although the funding agreement currently in place will expire soon and will have to be extended or renegotiated. We do not anticipate any interruptions in treatment for patients receiving Aldurazyme. ERT Funding for MPS II Since Elaprase enzyme replacement therapy for MPS II was not recommended for funding by the Common Drug Review’s (CDR’S) committee, it has been up to provincial, territorial, and federal funders to either follow that recommendation, or decide to fund regardless. Children in BC, Alberta, and Quebec area now being treated (albeit in Quebec, the funding is through private insurance), and Ontario’s new Drugs for Rare Diseases program is funding patients in Ontario on a case-by-case basis. Funding is not available in Sas- U.S. and European Rare Disease Organizations Sign Strategic Alliance Danbury, CT-----The leading advocacy groups for Americans and Europeans with rare diseases—the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS)—have signed a Memorandum of Understanding to join forces on several key strategic initiatives on behalf of rare disease patients and their families. The intent is to increase global awareness, promote research and the development of new treatments, and provide advocacy for more compassionate public policies. "Collaboration between our two organizations will make both stronger and more effective in representing our constituents," said Peter L. Saltonstall, President and CEO of NORD. "Since patients with rare diseases may be located anywhere in the world, international collaboration to support and advance their needs is extremely important. This strategic partnership will help us address issues and challenges that are essentially the same on both sides of the ocean." Yann Le Cam, Chief Executive Officer of EURORDIS, noted that "EURORDIS and NORD are in a unique position to promote solidarity between Europe and the US and help bridge the gap between those regions of the world that have progressed more than others in their strategies to address the needs of people living with rare diseases. We can be key facilitators to promote the common interest of people with rare diseases and to empower patient advocates all over the world." As part of their strategic partnership, EURORDIS and NORD will: Co-organize an annual global Rare Disease Day Establish common positions on key advocacy priorities Page 12 katchewan or New Brunswick, and we are working to address that situation. Thank you to those of you who have participated in our electronic letter-writing campaign: stay tuned for more ways you can help secure funding for ALL individuals with MPS II needing treatment. Parents of Canadian children affected with MPS II, and adults with MPS II, should discuss Elaprase with their children’s, or their own, physicians. Shire has established a 1-800# for families interested in exploring potential funding options available through private insurance. For more information on Elaprase or the Shire Reimbursement Support Program, please contact Kirsten at the Society’s head office. And What about MPS VI? A small number of Canadians are receiving ERT to treat their MPS VI. Funding decisions for Naglazyme will continue to be made on a case-by-case basis. Play a pivotal role in the International Conferences for Rare Diseases and Orphan Drugs (ICORD) to help expand the rare disease movement Collaborate in the development of international web media and social networking information and communication services Implement an international mentoring project for rare disease patient organizations Coordinate more closely activities to enhance relations with the pharmaceutical and biotechnology industry EURORDIS and NORD will kick off their collaboration with a joint public policy advocacy blog and shared online communities. This collaboration among patient advocacy leaders mirrors other recent developments. The U.S. Food and Drug Administration (FDA) and its counterpart in Europe, the European Medicines Agency (EMEA), have announced a collaborative effort to ensure appropriate conduct of clinical trials. The two agencies have also adopted a common application for "orphan" products—products being developed as treatments for rare diseases. A disease is considered rare in the U.S. if it affects fewer than 200,000 Americans. Almost 30 million or nearly one in 10 Americans have rare diseases. In the European Union, a disease is considered rare if it affects fewer than one in 2,000 people. There are 30 million Europeans with rare diseases. NORD, established in 1983, and EURORDIS, founded in 1997, are both non-governmental, patient-driven alliances of patient organizations and individuals dedicated to improving the lives of people with rare diseases. The NORD website is at www.rarediseases.org The EURORDIS website is at www.eurordis.org The Connection What you should know before submitting your tax returns Federal Tax Initiatives provide support to disabled individuals and their families CDB payment will be included in the Canada Child Tax Benefit payment. When filing a tax return, families will continue to be able to claim the disability amount and corresponding supplement for qualifying children. Disability Tax Credit For more information on the disability amount, visit CRA’s People with disabilities page or call T.I.P.S. at 1-800-267-6999. The Disability Tax Credit is a non-refundable tax credit used to reduce income tax payable for eligible individuals. To be eligible, you must meet all three of the following conditions: The CDB is based on family net income and provides up to a maximum of $199.58 per child each month to families with eligible children. For more information about the CDB, visit You must have a severe impairment in physical or men- CRA’s Child and Family Benefits page or call 1-800-387-1193. tal functions. Your impairment must be prolonged, which means it Child care expenses has lasted or is expected to last for a continuous period You or your spouse or common-law partner may have paid of at least 12 months. someone to look after your child who, at some time in 2009, A qualified practitioner certifies that your impairment was under 16 years of age or had an impairment in mental or is severe and prolonged and completes Form T2201, physical functions. Generally, the spouse or common-law partDisability Tax Credit Certificate, detailing the effects ner with the lower net income can claim these expenses, but of the impairment applicable to the basic activities of only if the expenses were paid so one of you could earn indaily living. come, go to school, or do research in 2009. If you are eligible for this credit but are unable to use all or part of it because you have no taxable income, More Medical and Disability-Related Information you can transfer it to your spouse, common-law partner, or other supporting person. The CRA has a guide about disability-related information which is meant for people with medical expenses or impairA supporting person may be able to claim all or part of a dements in mental or physical functions and anyone supporting pendant's Disability Tax Credit providing that both the supthese people. It gives information on eligible medical exporting person and the dependent were residents of Canada penses, services provided for people with impairments in menduring the tax year. tal or physical functions, as well as other information on income tax, excise tax, customs, and the goods and services How do I find out if I’m eligible? tax/harmonized sales tax (GST/HST). Find out if you may be eligible for the Disability Tax Credit by You can view and download this guide at: answering questions from a self-assessment questionnaire http://www.cra-arc.gc.ca/E/pub/tg/rc4064/rc4064-08e.pdf available at: http://www.taxspecialistgroup.ca/disability/content/eligible_ en.htm Need help filing your taxes? This questionnaire does not replace the form itself. It is provided to help you assess whether you may be eligible for the Disability Tax Credit. Child Disability Benefit Families with children who qualify for the disability amount may be eligible to receive the Child Disability Benefit (CDB). A child qualifies for the disability amount when you have approved Form T2201, Disability Tax Credit Certificate, for that child. The CDB will be calculated automatically for the current and the two previous benefit years for children who qualify and are under 18 years of age. If you want to get the CDB beyond these benefit years, send a letter to your tax office. The Winter 2009 Try the CRA Community Volunteer Income Tax Program If you need help to complete your tax return, your income is low, and your tax situation is simple, CRA volunteers are specially trained to help you. For more information about this free program, visit the CRA Community Volunteer Income Tax Program page or call us at 1-800-959-8281. In-person appointments If CRA cannot resolve your enquiry by telephone, you can arrange to meet with an agent at a tax services office by calling 1-800-959-8281 or if you are using a TTY, 1-800-665-0354. Our premises include ramps and other aids to make entry easier and to prevent undue physical demands. Page 13 Upcoming Conferences & Events Upcoming conferences & events: December 17-18, 2009: National MPS Society’s National Family Conference. Disney World, Orlando, Florida. www.mpssociety.org February 10-12, 2010: The 2010 “WORLD” Symposium, Miami, Florida. Hosted by the Lysosomal Disease Network. www.lysosomaldiseasenetwork.org May 8, 2010: Tacos for Trey. North Vancouver, BC. Visit www.treypurcell.com for more information. May 15, 2010: International MPS Awareness Day. Watch for news in our spring issue of the Connection. May 15, 2010: The 8th MPS CUP Fantasy Hockey Game & Gala. Vancouver, BC. www.mpscup.ca MPS Registries & Websites: The MPS I Registry: A resource available for your physician or health care professional that is dedicated to improving the understanding of MPS I. With the MPS I Registry , your physician can access your data and compare it to aggregate data from around the world. Ask your physician to call 1-800-745-4447, ext. 17021 for more information. The MPS II Registry: The Hunter Outcome Study (HOS) is a new registry dedicated to patients with MPS II (Hunter Syndrome). HOS is designed to support the gathering, analysis, reporting and sharing of data from around the world about Hunter syndrome. More information about Elaprase and MPS II (Hunter Syndrome) is available at www.elaprase.com. June 23-26, 2010: The 11th International Symposium on MPS & Related Diseases—Translating Research into Clinical Reality. Adelaide, South Australia. See the ad on page 15 for more information, and visit www.mps2010.com.au for updates. MPS IV Registry: Information about MPS IV can be found at www.morquio.com. Also available at this website is the Morquio registry—once registered, it is recommended that updates be made at least yearly, in order to ensure natural history data is captured to provide evidence critical for developments of treatments for MPS IV. Please join us at our 2010 National Family Conference! MPS Websites: Where: The Nottawasaga Inn Alliston, Ontario (about 1 hour from Toronto) When: July23—25, 2010 Why: To meet with other families and individuals affected by MPS, and renowned professionals…. Share, learn and laugh together! Travel bursaries will be available to Society members. For more information, visit www.mpssociety.ca or email info@mpssociety.ca. Page 14 www.MPSIdisease.com. A Genzyme-developed website with information and resources on MPS I. www.Aldurazyme.com. A Genzyme-developed site, providing parents and patients with information on Aldurazyme. www.lysosomallearning.com. A Genzyme-supported online resource relating to lysosomal storage disorders (LSDs). www.MPSII.com. A Shire-developed website, providing information about MPS II (Hunter Syndrome). www.MPSVI.com. A BioMarin-developed website, with information relating to MPS VI. www.MPSVI.net. Register for free on this site to connect with your MPS VI community. www.naglazyme.com. This new Biomarin-sponsored website is now live. You will find expanded content about MPS VI, its diagnosis and treatment with NAGLAZYME® (galsulfase) enzyme replacement therapy, and much more. www.goldinfo.org. Global Organisation for Lysosomal Diseases’ website, offering LSD information and resources, as well as videotaped presentations from conferences. Links to international MPS society websites can be found on our website: www.mpssociety.ca. The Connection 2010 International MPS Symposium The 2010 Organizing Committee invites you to join us in Adelaide for the 11th International MPS Symposium. Our wish for this meeting is for it to be a positive learning experience for all who attend and as such we wish to maintain the high scientific standards of previous meetings, by planning sessions that will be both informative about issues at the cutting edge of research and encourage vigorous debate of key current issues. Important Dates Registration open: Call for Abstracts: Call for Posters: Now Open (accommodation can also be reserved) January 2010 January 2010 The 2010 Committee is working hard on developing a program that looks at the cutting edge of science and clinical management of MPS and related diseases. The Family Program will closely follow the Scientific Program in areas of: Diagnostics/Prognostics Emerging therapies—cutting edge developments Skeletal/soft tissue Pathology CNS/Spinal Issues Management Issues for MPS Family and affected patients stories Children’s Program While parents are enjoying the Symposium the children will be having the time of their lives on an exciting and stimulating children’s program that is being developed for the 2010 Symposium at some of Adelaide’s top attractions. A fully serviced crèche or day care centre will be available for children under the age of 4 or for those who are too frail to participate in the planned activities. Entry into Australia All travelers, except New Zealand citizens, must obtain a visa or travel authority before traveling to Australia. www.mps2010.com.au WOULD YOU LIKE TO ATTEND THE 2010 MPS SYMPOSIUM? A limited number of $500 travel bursaries will be available through the Canadian MPS Society. Please contact us or visit our website for guidelines and registration forms. Application deadline: Feb 28, 2010. Winter 2009 Page 15 Research & Clinical Trials MPS I: that has been observed in children with Hurler from the time the patients are initially evaluated to the time they are one Aldurazyme (laronidase) enzyme replacement therapy was licensed for use by Health Canada on May 31, 2004, for long- year from transplantation. The study will involve four doses of term treatment in patients with a confirmed diagnosis of MPS laronidase given during a lumbar puncture approximately I, to treat the non-neurological manifestations of the disease. three months before transplantation, at the time of admission to the hospital for the transplant, three months after the transFor more information on Aldurazyme, please visit plant, and six months after the date of the transplant. www.aldurazyme.com Principal Investigator Dr. Paul Orchard can be contacted for more information at 612-626-2961 or orcha001@umn.edu. MPS I Intrathecal ERT for Spinal Cord Compression: A one-year extension study has been approved. Enzyme replacement therapy (ERT) has been developed for MPS I. ERT MPS II: helps many physical ailments due to the disease, but does not On June 15, 2007 Elaprase enzyme replacement therapy was approved by Health Canada for the treatment of MPS II. treat the central nervous system due to inability to cross the blood brain barrier. The purpose of this study is to test deliv- Shire MPS II Intrathecal Study: ery of ERT to the spinal fluid via intrathecal injection in paDr. Joseph Muenzer and will be conducting a Phase I/II tients with MPS I. In this pilot study, recombinant human α- (Safety/Dosage) trial using intrathecal ERT for the treatment L-iduronidase will be administered intrathecally once per of MPS II, with a goal of preventing central nervous system month for four months to individuals age 8 and older with involvement. This study will take place at the University of the Hurler-Scheie and Scheie forms of MPS I and spinal cord North Carolina in Chapel Hill, NC. If you are interested in compression. If successful, intrathecal delivery could represent obtaining more information about the clinical trials, please a practical, straightforward method of treating central nervous contact Dr. Muenzer (919)966-1447, or study coordinator system disease due to lysosomal storage. Heather Preiss at (919)843-5731 or hpreiss@med.unc.edu. Primary Outcomes: Safety of intrathecal enzyme treatment by blood and spinal MPS III: fluid tests each month; improvement in neurologic signs reDr. Grzegorz Wegrzyn of Poland has been researching sublated to spinal cord compression, by neurologic examination strate reduction therapy and the effect of genistein on syntheand Japanese Orthopedic Association Scale each month; imsis of glycosaminoglycans. provement in neurologic symptoms related to spinal cord Shire Pharmaceuticals Group, as part of its research compression, by subjective assessments and independence of to evaluate new approaches to the problem of treatment of the functioning scale each month; improvement in mobility, by six-minute walk test each month; improvement in spinal cord central nervous system, is hoping to move its MPS III-A program forward. www.shire.com. compression by MRI imaging and somatosensory evoked potentials at baseline and four months; improvement in lysosomal storage by spinal fluid glycosaminoglycan levels at MPS IV: each treatment. In late 2008 the board of directors of Vivendy Therapeutics Secondary Outcomes: announced the cessation of Vivendy’s natural history program Improvement in spinal fluid pressure, by opening pressure as well as further medical activities related to the development measurements at each intrathecal treatment; improvement in of enzyme replacement therapy treatment for MPS IV A. hydrocephalus and other brain lesions by MRI at baseline and BioMarin Pharmaceutical Inc. announced April 21, four months. 2009 the initiation of a phase I/II clinical trial for BMN-110 Expected Total Enrollment: 10 or N-acetylgalactosamine 6-sulfatase (GALNS), intended for Additional information can be obtained at the treatment of MPS IV A. http://www.clinicaltrials.gov/ct/show/NCT00215527?order= Phase I/II clinical trials (safety) began in Q1 2009 1 or by contacting Principal Investigator Dr. Patricia Dickson with about 40 patients in the UK and there are about 20 enat 310-222-4145 or pdickson@ucla.edu. rolled in the Phase II study. The Phase III trial will likely inMPS I Intrathecal ERT for Children Being Considered for Transplant: The University of Minnesota in Minneapolis has recently obtained FDA approval for the delivery of laronidase into the spinal fluid of children with MPS I (Hurler syndrome) being considered for marrow/cord blood transplantation. The goal of these studies is to decrease the neurophsychologic decline Page 16 clude 50-100 patients in several centres, and should begin sometime in late 2010. The link to BioMarin’s MPS IV A program website is www.morquiobmrn.com - this site is a great place to look for current information. It will be updated at least four times per year, and of course, more often if there is significant news. In addition, visitors have the option to register on the website to The Connection Research & Clinical Trials receive news about updates via email. Further information about MorCAP is also available on ClinicalTrials.gov at this link; http://www.clinicaltrials.gov/ct2/show/NCT00787995?term =morquio&rank=2. Patients or physicians who are interested in participating in MorCAP (see announcement on page 18) can contact the Montreal site’s study coordinator, Gail Ouellette at gail.ouellette@mail.mcgill.ca or phone: 819-543-0550. for more information. If you have particular questions about operational aspects of BioMarin’s trials, you can contact Candice Henkel at chenkel@bmrn.com or 415-506-6973. For additional medical questions related to MPS IVA and the clinical details of BioMarin’s program, please contact the Medical Director for BioMarin’s MPS IVA program, Celeste Decker, at cdecker@bmrn.com or 415-5066469. MPS VI: The U.S. Food and Drug Administration (FDA) granted marketing approval for Naglazyme(TM) (galsulfase), the first specific therapy approved for the treatment of MPS VI VI , on June 1, 2005 . Editor’s note: There is no word on when (or if) BioMarin will apply for licensing approval for Naglazyme in Canada. For more information, please contact BioMarin Patient and Physician Support (BPPS) at 1-866-906-6100 or bpps@bmrn.com. MPS VII: A gene therapy clinical trial for MPS VII, also known as Sly syndrome, has been put on hold pending additional data. Pompe Disease Myozyme® (alglucosidase alfa), a recombinant form of human acid alpha-glucosidase (GAA), was approved by Health Canada on August 14, 2006 for the treatment of patients with Pompe disease (GAA deficiency). For more information on Pompe disease, please visit Canadian Association of Pompe’s (CAP’s) website: www.pompecanada.com. Research Grant RFA ***** The Canadian MPS Society is requesting applications for its 2010 $100,000 (over 2 years) Research Grant for research into MPS Diseases *** Grant guidelines and application forms are available for download at www.mpssociety.ca. Application deadline: February 1, 2010 Funding date: March 30, 2010 DID YOU MISS THE VANCOUVER SYMPOSIUM? OR WERE YOU UNABLE TO CATCH ALL THE SESSIONS WHILE YOU WERE THERE? All scientific sessions were videotaped and are available for viewing, along with their accompanying slideshows, at www.goldinfo.org. To view the sessions on the GOLD website, you will need to register if you have not done so before. Registering only needs to be done once. Click on “Video Presentations” under “Education and Information” on the GOLD homepage’s left sidebar. Then, click on “register here” in the first paragraph, which will open a registration form. You will be asked to give your email address as a username, choose a password, and select the organisation of which you are a member: Please select Canadian Society for Mucopolysaccharide & Related Diseases Inc. from the drop-down menu. GOLD will not give your information to third parties. All presentations from the family sessions are available for download at www.mpssociety.ca. Winter 2009 Page 17 Research/Clinical Trials MORCAP CLINICIAL STUDY FOR ÉTUDE CLINIQUE DU MORQUIO SYNDROME TYPE A SYNDROME DE MORQUIO TYPE A The Montreal Children’s Hospital is the Canadian site for a multinational clinical study of Morquio disease type A or Mucopolysaccharidosis IV type A (MPS IVA) sponsored by BioMarin Pharmaceutical Inc. The Morquio A Clinical Assessment Program (MorCAP) is designed to provide a fuller understanding of MPS IVA syndrome in preparation of phase III clinical trials of a potential treatment. Patients of all ages are eligible for the MorCAP study. Participation will require a visit of 2 or 3 days to the Montreal Children’s Hospital in Montreal. Travel and lodging expenses will be reimbursed. No experimental drug is administered during the visit. The study comprises a physical examination of the affected patients, blood and urine tests, a questionnaire concerning medical history, cardiac and respiratory function tests, and endurance tests. BioMarin is also conducting a Phase I/II study of an experimental enzyme replacement therapy for Morquio A. The insights gained from theMorCAP study will help BioMarin design the phase III trials. More information can be found at http://www.morquiobmrn.com/ or at www.clinicaltrials.gov If you are interested in participating in the MorCAP study at the Montreal Children’s Hospital or if you want more information, contact the study coordinator, Gail Ouellette (email: gail.ouellette@mail.mcgill.ca or phone: 819-543-0550.) L’Hôpital de Montréal pour enfants est le site canadien pour une étude clinique internationale de la maladie de Morquio type A ou mucopolysaccharidose IV type A (MPS IVA). Cette étude est commanditée par BioMarin Pharmaceutical Inc. L’étude MorCAP (Morquio A Clinical Assessment Program) a comme objectif de mieux comprendre le syndrome MPS IVA en vue d’études cliniques phase III pour un traitement potentiel. Les patients de tout âge sont éligibles à l’étude MorCAP. Leur participation nécessitera une visite de 2 à 3 jours à l’ Hôpital de Montréal pour enfants à Montréal. Tous frais de transport et d’hébergement seront remboursés. Aucun médicament expérimental ne sera administré durant cette visite. L’étude comprend un examen physique, des tests de sang et d’urine, un questionnaire sur les antécédents médicaux, des tests de fonction respiratoire et cardiaque et des tests d’endurance. BioMarin évalue présentement un médicament expérimental (thérapie de remplacement enzymatique) dans une étude de Phase I/II. Les résultats de l’étude MorCAP permettront à BioMarin de préparer les études cliniques de Phase III pour ce médicament. Vous pouvez trouver plus d’information sur ces études à http://www.morquiobmrn.com/ ou www.clinicaltrials.gov. Si vous êtes intéressé à participer à l’étude MorCAP à l’Hôpital de Montréal pour enfants ou si voulez obtenir plus d’information, contactez Gail Ouellette, coordonnatrice de l’étude (courriel : gail.ouellette@mail.mcgill.ca ou téléphone : 819-543-0550). Recruitment Open for New Study Led by Dr. Hal Siden "Charting the Territory: Determining and Documenting Trajectories for Families Where a Child Has a LifeThreatening Condition" is a new multi-centre, longitudinal, descriptive study led by Dr. Rose Steele and Dr. Hal Siden. Dr. Siden is the Medical Director of Canuck Place Children’s Hospice and a Clinical Associate Professor at UBC. This 5-year CIHR-funded study will identify and track children diagnosed with progressive neurological, metabolic, or chromosomal conditions. We will also follow their families to determine and document clinical progression of the child’s condition and the associated experiences of the family. Researchers aim to improve understanding of how to best care for these vulnerable children and their families. Researchers have begun enrolling families through the Neurology, Biochemical Disease and Genetics clinic at BC Children’s Hospital. For more information, please visit the study website: http://www.chartingterritory.com/ Page 18 The Connection Research/Clinical Trials questions or sensitive stimuli will be used in the neuropsychological testing. MRI scans do not involve any radiation. There are no known risks associated with magnetic resonance scanning itself. We take care not to scan people with some We are inviting individuals over the age of with MPS I, II or types of metal in their bodies (from surgery or accident) and VI to participate in a longitudinal research study seeking to people with pacemakers or programmable shunts should not better understand the brain basis for the learning difficulties enter a magnetic resonance scanning facility. We will ask you sometimes found in MPS disorders. You or your child must detailed questions about these risks to ensure that it is safe be over the age of 6 and able to cooperate in an MRI imaging for the participant to enter the magnet. The blood draw has study without any sedation. We are studying the central nervusual risks of bruising but it is only about the amount of two ous system so that we can better understand the brain teaspoons. changes in MPS disorders to find better ways of treating these problems. Air and ground transportation and hotel for one night will be provided to the University of Minnesota, Minneapolis camThe participant will be seen for two sessions in one day, one pus, for two persons. for neuropsychological testing that will last about two hours to three hours, and the other for brain imaging which will last You may contact or Kate Delaney at 612-625-1143 for one hour. Neuropsychological tests will include a brief (delan011@umn.edu) or Elsa Shapiro at 612-625-1618 test of cognitive ability and attention, and several tests of (shapi004@umn.edu) for more information. Thank you for memory. Some of this testing will be done on a computer. reading this description This testing will be done in the Center for Neurobehavioral Development at the University of Minnesota. You will also Elsa Shapiro, Ph.D. come to the Center for Magnetic Resonance Research. The participant will be placed on a table in the scanner. Imaging Principal Investigator Professor of Pediatric and Neurology will require lying still for about 30 to 35 minutes. During this time the participant can watch a video. We will be doing University of Minnesota two procedures. One procedure is an MRI that allows us to calculate the volume of various brain structures (volumetric ****************************** MRI). The other MRI procedure allows us to visualize the structure in the connections between one part of the brain Editor’s Note: The Hospital for Sick Children in Toronto will be a and another (DTI – Diffusion Tensor Imaging). This study site for this study with Dr. Julian Raiman acting as the Principal will be different than clinical studies because we are using a Investigator. Canadian patients are welcome to participate in this more powerful magnet called a 3 Tesla scanner. Studies with study at the Toronto site or, if more convenient, at the Minneapolis, a more powerful magnet are more sensitive to the details that Minnesota or Portland, Oregon sites. we are investigating in this study and are just as safe as less powerful magnets. We will also draw a small amount of blood Please contact the Society for more information. to measure new biomarkers that are being developed by Dr. Clarke at the University of British Columbia. Dear adult with or parent of a child with MPS I, II, or VI: None of these tests are in any way harmful. No embarrassing EXPERIENCES OF FAMILIES OF CHILDREN WITH RARE DISORDERS Principal Investigator: Prof. William H. McKellin, PhD, Anthropology, The University of British Columbia. Dr. McKellin is inviting families to participate in this study of families of children with rare medical diseases or disorders. This study aims to hear directly from you about health care, medical research, social services, and community support. If you live in the Vancouver area and are interested in participating, please contact Dr. McKellin at 604-822-2756 or mcke@interchange.ubc.ca. Winter 2009 Page 19 2nd JAPAC Educational Forum for The Taiwan MPS Society graciously hosted the 2nd JAPAC Educational Forum for Families and Caregivers on MPS on October 9th and 10th in Taipei. I was so pleased to be able to attend this very interesting meeting, where representatives from Asian countries—including Taiwan, Japan, China, South Korea, Malaysia, the Phillipines, Hong Kong, and Singapore—discussed how to better support patients and families affected by MPS diseases in their own countries, and how to better support each other as they work as a collective, now called “The Asia-Pacifica MPS Organization.” I was invited to give a talk about the Canadian MPS Society, and Barbara Wedehase (USA), Christine Lavery (UK), and Wendy Boon (Australia) added to the international perspectives. The Forum was held concurrently with the 12th Annual LSD Symposium (a scientific meeting), and was followed by the International Conference of National Policies and Actions on Rare Diseases on October 12th, so altogether over four hundred delegates were in attendance and took part in joint dinners and outings, featuring a keynote address by Dr. Roscoe Brady and performances by extremely talented Taiwanese dancers, drummers, and singers. A highlight was listening to the incredible voices of the Taiwan Foundation for Rare Disorders’ children’s choir—their songs filled our hearts with hope. Virginia Tsai, president of the Taiwan MPS Society did such a Page 20 fabulous job of hosting us and I certainly appreciated having the opportunity to learn so much about Taiwanese culture and to be inspired by all the fabulous initiatives taking place across Asia in support of those with MPS. Kirsten The Connection Families and Caregivers on MPS Wonderful memories from Taiwan! Clockwise from top left: TFRD’s Children’s Choir; Kirsten with new friends from China and Hong Kong, and with TFRD’s founder Serena Wu; holding the beautiful lanterns that were presented as keepsakes of the conference. Bottom left: Virginia & Dr. ShuanPei Lin with Wendy, Barb & Kirsten. Bottom right: Virginia with her children. Opposite page, left: William Luo giving an inspiring speech about his life with MPS II; right: the gong! Winter 2009 Page 21 In the News Particles Detected in Vials from Genzyme's Plant Not Expected to Impact Aldurazyme or Naglazyme NOVATO, California, Nov. 13, 2009 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) announced today that Genzyme notified the company that, in rare circumstances, it has detected foreign particles in some products filled at the Allston Landing facility. To ensure that patients are not exposed to foreign particles during product administration, Genzyme has issued a "Dear Doctor" letter to all physicians treating patients with enzyme replacement products that it markets, including Aldurazyme. The letter states that foreign particles have been found in some vials filled at Genzyme's Allston Landing facility and reminds physicians, as a preventive measure, to use a 0.2-0.22 micron filter during administration. For Aldurazyme, this is essentially a reminder as the Aldurazyme approved product label has always recommended the use of a 0.22 micron filter when administering the drug. Accordingly, BioMarin does not expect this letter to have any substantial effect on the usage of Aldurazyme, or on the company's financials. Due to a mutual decision by BioMarin and Genzyme, BioMarin has been transitioning Aldurazyme production to other fill finish facilities. The last fill finish of Aldurazyme at Allston Landing was in September 2008. BioMarin is committed to taking all efforts to maximize patient safety for all of its products. Similar to the Aldurazyme label, the Naglazyme product label also recommends the use of a 0.22 micron filter prior to administering the drug to patients. Additionally, BioMarin utilizes numerous process controls to minimize the presence of particles in its products, including redundant filtration during the manufacture of drug product. About BioMarin BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. Other product candidates include PEGPAL (PEGylated recombinant phenylalanine ammonia lyase), which is in Phase 2 clinical development for the treatment of PKU and GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in Phase 1/2 clinical development for the treatment of MPS IVA. For additional information, please visit www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release. Forward-Looking Statement This press release contains forward-looking statements about the business prospects of BioMarin Pharmaceutical Inc., including, without limitation, statements about: the manufacture and supply of Aldurazyme and Naglazyme and the safety profile of these products. These forward-looking statements are predictions and involve risks and uncertainties such that actual results may differ materially from these statements. These risks and uncertainties include, among others: the actual experience in manufacturing these products, future unexpected adverse event reports, , and those factors detailed in BioMarin's filings with the Securities and Exchange Commission, including, without limitation, the factors contained under the caption "Risk Factors" in BioMarin's 2008 Annual Report on Form 10-K. Stockholders are urged not to place undue reliance on forward-looking statements, which speak only as of the date hereof. BioMarin is under no obligation, and expressly disclaims any obligation to update or alter any forward-looking statement, whether as a result of new information, future events or otherwise. BioMarin®, Naglazyme® and Kuvan® are registered trademarks of BioMarin Pharmaceutical Inc. Aldurazyme® is a registered trademark of BioMarin/Genzyme LLC. SOURCE BioMarin Pharmaceutical Inc. investors, Eugenia Shen, +1-415-506-6570, or media, Susan Berg, +1-415-506-6594, both of BioMarin Pharmaceutical Inc. Just the tip of the iceberg - Hope for inherited childhood disorders Top South Australian medical researcher honoured nationally AUSTRALIAN INSTITUTE OF POLICY AND SCIENCE—November 9, 2009 Professor John Hopwood, South Australian Scientist of the Year 2008, will this evening follow in the footsteps of some of Australia’s greatest medical researchers, including immediate past winner Professor Ian Frazer and Nobel Laureates Professors Barry Marshall and Robin Warren, by being awarded the 2009 CSL Florey Medal. Professor Hopwood today joins a cohort of extraordinary Australian medical researchers who are at the forefront of breakthroughs globally, and who have dedicated their lives to basic research all the way through to making a difference to our lives through prevention and treatment. (Please visit our website to read the full press release.) Page 22 The Connection In the News Swedish Driver Kalle Dejemyr (22 years old with MPS type II) Finishes 9th in the Swedish Super Kart Championship At the age of eleven Kalle Dejemyr was diagnosed with Hunter syndrome. He participated in the natural history and pharmaceutical trial in Mainz in 2005 and now receives home treatment with Elaprase. In the autumn of 2007 Kalle was highlighted in the media when the hospital management decided to discontinue his treatment because of the cost. Kalle, his family and the MPS society fought for his right to treatment and the decision was changed after TV and the social minister was involved. Medication has worked flawlessly and he now feels almost completely healthy. Racing is one of Kalle's greatest interests, where he can compete against others on the same terms. Kalle is now driving/racing his second season in Super Kart and has already achieved several podium finishes and was ranked in 9th place in this year's Swedish Super Kart Championship. “I've had a tough season, have only been in goal in five of eight finals. It all started when my engine broke down on the very first contest. Have been forced to drive with spare engine, most of the SM series. Finished in a good way with a 3rd and a 4th placing at the last race. We have already started planning for next season. I've been invited to run a race in Dubai 14-16 January 2010. It would be a dream to drive in that race, but unfortunately we do not have the financial means to participate. In Sweden is it difficult to find sponsors, the hope is that I somehow can gather what is lacking in the budget says Kalle.” Hunter Disease eClinic ***** This amazing new educational software, developed by Sick Kids’ Lysosomal Research Group and launched at our International MPS Symposium, is now available through the Hospital for Sick Children’s website! The direct links to the educational software are: Ebook: http://www.sickkids.ca/research/lysosomalresearchgroup/contents/Hunter/Hunter_eBook.asp Eclinic: http://www.sickkids.ca/research/lysosomalresearchgroup/contents/Hunter/Hunter.asp Users need “Flash Player” installed on their computers in order to be able to view the program, and should be reminded not to use the browser back button. The Hunter eClinic can also be accessed from the Lysosomal Research Group’s web-site under "NEW: Educational Resources" on the group home page: http://www.sickkids.ca/lysosomalresearchgroup/ Check it out!!!! Winter 2009 Page 23 Fundraising—Toronto Waterfront Marathon Team MPS Continues Strong In the early hours of September 27, 2009, a team of dedicated individuals assembled again to represent Team MPS at the Scotiabank Toronto Waterfront Marathon. We were blessed with excellent (dry!) weather, which was a novelty this summer. Leading the team with an inspiring performance was Jenn Elder, our sole half marathon runner. Also helping to represent was Kelly Leradza from Genzyme, and all five members of the Byrne clan. A special mention goes out to Team Billie: Robin Tewkesbury, Vanessa Rooney, Tracy Davison and Shannon Boyd, all walking in memory of Billie Tewkesbury. It was great to see Robin again! I am pleased to report that our runners managed to raise $4,353.00 for the Canadian MPS Society. Way to go team!!! Judy Byrne Top: Team MPS gets ready to race! Left: Colin Byrne takes a one kilometer running break on Dad Terry’s shoulders. Above: Jenn Elder with daughter Anisa Mia (MPS I H/S), proudly wears her 1/2 marathon medal. Page 24 The Connection Fundraising—Toronto Waterfront Marathon Clockwise from top left: Team MPS believes! More MPS Team members get ready to race; Anisa Mia Elder (MPS I H/S) with Sarah Byrne (MPS I H) enjoy a snack; Team MPS members getting close to the finish...wheelchairs in the lead! Big smiles after the race for all Team MPS walkers and runners; Sarah Byrne (MPS I H) runs with Dad Terry. Thanks, team! Winter 2009 Page 25 Fundraising—A Night of Enchantment Right: Emma-Rose Grenon-LeMaitre (MPS I H) cuddles with her Dad Jim LeMaitre Above: Kirsten accepts $5000.00 cheque from Lara Pietrolungo, organizer of A Night of Enchantment On October 23, 2009, more than 300 guests attended the Emma-Rose Fund’s first inaugural fundraising gala, A Night of Enchantment, at Le Parc in Concord, Ontario. A major accomplishment, this first time affair raised over $50,000 to support families of children with Mucopolysaccharide (MPS) diseases. To view the evening’s photos and the Emma-Rose tribute video please visit http://www.emma-rose.ca/index-3.html. The Emma-Rose Fund’s main purpose is to increase awareness of MPS diseases and raise dollars to support parents of children with MPS. As you might know, proceeds from the gala will soon be donated to your Family Assistance Program and to the Patient Amenities Program at the Hospital for Sick Children. We feel that these two programs allow parents across Canada to have direct access to funding to help care for their child with MPS disease. This year, on behalf of the Emma-Rose Fund, it is our pleasure to donate $5000 to the Canadian MPS Society’s Family Assistance Program. All necessary documents for issuance of tax receipts will be forwarded to you shortly. We thank you for you support and continued well wishes. We hope that this is only the beginning of a great partnership. Should you require any further information, please don’t hesitate to contact us. Warmest Regards, Lara & Rudy Pietrolungo Founders Emma-Rose Fund Left: Emma-Rose surrounded by family and friends at the Emma-Rose Fund’s inaugural fundraising gala Page 26 The Connection Fundraising—Walk with Nature On September 26, 2009 we held our 6th MPS Walk with Nature. The weather was great, the apple pie super and the company fantastic. Thanks so much to our supporters who have followed us from year to year and from town to town. We raised $1010.00 in total for the Genetic department at the Montreal Children's Hospital and The Canadian MPS Society. Our faithful Dr. Serge Melancon and his family were present, and as usual, the hospital Mascot. It always amazes me how rare these diseases are, but what is more amazing is that out of A beautiful day for the 6th MPS Walk with Nature total of $88.00 Our 18 speed bike was won by Lise Cournoyer from Iron Hill Quebec. The bike was donated by Michele LeFevre who works for The Montreal Children's Foundation; her Monika Nelis-Dupont (MPS I H/S) enjoying the walk with her energetic friends about 35 people who attended our walk there were three MPS families with us in the small town of Sutton Quebec. The strength that MPS families bring to each other is a great blessing. I would like to thank all the donors who donated items for our Chinese auction. Our 50/50 draw was won by Henry St-Amour from Sutton and he donated it right back: a Monika was all tuckered out and sat in her pink limo for the 2 km. ride back to the hall. friend had won it at a previous event. Thanks to Sylvie for organizing the Chinese auction once again. It was a lot of fun and we had over 30 auction items, and Lisa Phaneuf did a great job of keeping track of the item winners. I was very happy to see Jim and Adele LeMaitre, now from Quebec, come out and join our walk. And last but certainly not least, we truly do appreciate the support of the Royal Canadian Legion who donated the hall, their help, their time. Nathaniel Phaneuf (MPS II), with Dad Russell & sister Chelsea chat with Caramel along the way. Winter 2009 THANKS TO ALL! The Nelis-Dupont family Page 27 Fundraising——Hope Shines Bright Gala Celebrating The Sanfilippo Children’s Research Foundation’s 10th Anniversary at the Hope Shines Bright Gala April 2009 The room was sparkling with shimmering glitter, dazzling lights, twinkling disco balls, shining mirrors, and almost 700 radiant smiles! The Hope Shines Bright 10th Annual Evening for Elisa reflected everyone’s excitement as the Foundation marked ten years of successful fundraising, awareness building and promising research that’s producing measurable results. This Gala was also a celebration of Elisa’s fifteenth birthday. By the mid teens, many Sanfilippo children have been confined to their beds or, worse, have Elisa Linton (MPS IIIB) with her family on stage at the passed away from the illness. We were all so happy to see Hope Shines Bright Gala Elisa return again this year as belle of the ball and even appear at the podium along with the rest of the Linton family. Just over $190,000 was raised in this one evening alone—a sum that makes the Foundation proud and grateful, especially considering so many people are feeling the pinch of tough economic times. Returning as Emcee for this special year was CFRB morning man Bill Carroll. Herbie Kuhn, the on-court voice of the Toronto Raptors, was our lively Auctioneer for the tenth year running. And guest speaker Simon Ibell, who has a related metabolic condition (MPS ll - Hunter’s Syndrome), shared his unique story of believing and never giving up hope in finding a cure. To mark the 10th year, 12 individuals were recognized for their outstanding donation and contribution of professional services and unique gifts to the Foundation for each of the past ten years. Without their help since incepThe room before the arrival of the almost 700 guests tion of the SCRF, we would not be able to contribute 97 cents of every dollar to research. Our sincerest appreciation was extended to: Dr. Joe Clarke, Paul Mosey, Wendy Rae, Barry Pettit , Sarah Double, Kim Aikenhead , Tracy Galvin, Herbie Kuhn, David Kraulis, Mark Boehmer, Tracy Keenan, David Levy & Bill Carroll. Heartfelt thanks also goes to our generous and loyal donors for contributing hundreds of amazing auction items, over 80 volunteers who helped Elisabeth and Randall pull the evening together, and to our guests for keeping precious hope alight. Thanks, too, to everyone who sent in donations in lieu of attending—these funds make a huge difference in our mission to find a treatment or a cure for Sanfilippo. Stay tuned for more details of next year’s gala event which will celebrate Elisa’s “Sweet 16.” It’s never too early to get involved. If you would like to join the Gala Organizing committee, please Simon Ibell (MPS II) speaks to gala guests contact Elisabeth at alifeforelisa.org or 416-223-1911. Page 28 The Connection Fundraising Canadian MPS Jeans Day at Cove Cliff Elementary School in North Vancouver Thanks so much to everyone who donned their jeans and supported Canadian MPS Jeans Day at Cove Cliff Elementary School on October 2nd. Nicklas was diagnosed with MPS I in 2001 when he was a kindergarten student at Cove Cliff, and we have been so touched over the years by the outpouring of support from our school community. Even though Nicklas is now a high school student at Seycove Secondary School, Cove Cliff continues to hold a Jeans Day annually, and this year raised over $1,200.00! Thanks so much, Cove Cliff, for caring so much about Nicklas and all kids with MPS! Kirsten Harkins Above left: Jansen Harkins (far left, top row) and his grade seven class; above: Jonas Harkins (2nd from left, top row, beside his teacher Mrs. McAllen) and his grade 3/4 class on Jeans Day. FUNDRAISING COOKBOOK With the support of local merchants, Mary Nelis, mother of Monika Nelis-Dupont (MPS I H/S), will be working on a cookbook this winter. The cookbook will raise funds for the Canadian MPS Society. Please contribute by sending your favourite recipes to her at mary.nelis@sympatico.ca. The cookbooks will be available for purchase in 2010. Friends of Ferrari Luncheon The Harkins family was pleased to represent the Canadian MPS Society at an annual charity luncheon hosted by Vancouver-based “Friends of Ferrari.” The Society has been honoured to receive funds through Friends of Ferrari’s mini-Ferrari races, and we were pleasantly surprised when Franco Corona, founder of Friends of Ferrari, announced that we will be receiving additional funds at year-end. Many thanks to Franco and his wife Suzann, and all the other dedicated volunteers who have helped them raise $1,257,000 for 42 charities. For more information, visit www.friendsofferrari.com. Franco Corona poses with Jonas, Kirsten & Nicklas Harkins, and a beautiful red Ferrari! Winter 2009 Page 29 Fundraising– Canadian MPS Jeans Day Help bring awareness of MPS Diseases into your community! Hold a Canadian MPS Jeans Day on any day of the year— just follow these simple steps: Submit a proposal to your school's principal or your employer **email Kirsten (kirsten@mpssociety.ca) or Jill (jill@mpssociety.ca) for a word template** Email or call the head office to let us know how many people you anticipate will be participating. You will receive a Canadian MPS Jeans Day package with enough stickers for your event. Packages will also contain 2 posters, 5 colour brochures (you will have to photocopy enough brochures to distribute at your event.), and a donor information sheet to record the names and addresses of those wishing to receive income-tax receipts for donations of $10.00 and over. Fill in the event date and expected donation amount on your posters (the expected donation is up to your discretion depending on the location: we recommend between $1.00—$5.00) and advertise Canadian MPS Jeans Day at your school or workplace. Email us for an 8x11 poster PDF if you would like to print out additional posters. Organize volunteers to collect donations and distribute stickers and brochures on the morning of your event. Ensure those who donate $10.00 or more fill out the donor form completely if they wish to receive income tax receipts. Take a photo at your event to share with our members in the next issue of the Connection! Submit your donations, donor forms, photos, and a brief write-up, with photos if possible, about your event within 30 days of the event date. Canadian MPS Jeans Days are easy to hold and are excellent opportunities to raise awareness and funds for the society. Many of our members have found them to be extraordinarily helpful in educating school communities about our children's unique conditions. Please consider holding a Canadian MPS Jeans Day at your child's school or at your workplace. Would YOU like to organize a fundraising event for the Canadian MPS Society? Look for great fundraising ideas in these pages, or contact us at info@mpsociety.ca! Page 30 The Connection On-going Fundraising On-going Fundraisers: More Great MPS Fundraising Ideas: Used Stamps: Sign up through your United Way Donor Choice Program. Designate The Canadian MPS Society as your “OTHER” choice by providing our name, address and Charity # 129030409 RR0001. Double your support by enrolling the Society in matching gift programs, available through many companies. Organize a walk or run Have a garage sale Organize a Sports Tournament Participate in Craft Sales Organize a Canadian MPS Jeans Day Host a party: i.e. Pampered Chef, Discovery Toys, Partylite. Organize a dinner or barbeque Remember, when you sponsor a fundraiser you are not only raising money to help find a cure but you’re also educating the public about MPS. Please save your stamps and mail to our stamp collector: Laura Wassilyn 5 Kitson Drive Scarborough, ON M1M 3C7 TIPS ON MAILING STAMPS: Please trim stamps leaving 1/4 inch of paper around them. Any with tape or damaged perforations should NOT be submitted as they cannot be sold. Thanks for your support! Fundraising Reminders: Contact the office and request an event proposal form. Fill out and submit the form so that the head office knows the details regarding the events you are holding. Don’t forget to submit a brief article, with photos if possible, for the Connection about your fundraising success stories and suggestions—they are terrific resources for other families planning events. Thanks for your enthusiastic support! The Canadian MPS Society’s tribute card program is a special way of paying tribute to a friend or a loved one. Send an MPS tribute card for any occasion as a meaningful gift to support children affected with MPS: to welcome a new baby, to celebrate a birthday or anniversary, to memorialize the passing of a friend or relative or to say thank you to someone special. MPS tribute cards may be ordered by making a contribution of $10.00 or more. Contact the office with your request: sympathy or tribute cards are sent out the same day and income tax receipts are issued. Do you need respite care? Caring for an exceptional child can be exhausting—The Maxwell Alexander Settari Fund has generously donated funds to our Family Assistance Program specifically for respite care. Interested members should submit a Family Assistance Program application form, found on page 34, and contact Kirsten for guidelines. Winter 2009 Page 31 Society Merchandise CANADIAN MPS SOCIETY GOLF SHIRTS! AVAILABLE IN MEN’S XXL, XL, L, M, & S, AND WOMEN’S (fitted style with buttons) L, M, & S. $40.00 (includes shipping) ALSO AVAILABLE ARE A LIMITED NUMBER OF CHILDREN’S T-SHIRTS (These shirts come in Youth L, M and S and are for sale for $12.50 (including shipping). TO ORDER, visit our online store at www.mpssociety.ca or call us at 604-924-5130 or on our toll free number 1-800-667-1846 NEW! “Expression of Hope II” art cards are now available! These inspiring cards come in a pack of 20 original designs (including the beautiful piece to the left). View all selected pieces as well as all submissions to Expression of Hope II at www.expressionofhope.com. Artist: Happy Country: Taiwan Condition: Fabry Order your art cards for $25.00 per package (including shipping) by visiting our online store at www.mpssociety.ca, or calling 604-924-5130 or 1-800-667-1846. “I dream of having a pair of my own wings, to fly freely beyond the sky, so no matter how far I go, I won't feel tired. I close my eyes and happily spread my wings heading to my Paradise.” ORD ER YOUR CANADIAN MPS SOCIETY AWARENESS BRACELETS! Our bracelets are royal blue and inscribed with “BELIEVE - MPSSOCIETY.CA” Our awareness bracelets come in three sizes: large, medium, and small and are available for a minimum donation of $2.00 per bracelet, plus shipping. Please place your order through our online store at www.mpssociety.ca or call us at 604-924-5130 or 1-800-667-1846 and help spread the word about MPS diseases! Page 32 The Connection The Canadian Society for Mucopolysaccharide & Related Diseases Inc. 2010 Membership Form To register or renew your membership, please submit this form or go towww.mpssociety.ca (please log in to your account when renewing) First/Last Names: _________________________________________________________________________________ Address: _______________________________________________________________________________________ City: __________________________________ Province: _________________ Postal Code: __________________ Telephone: ________________________________ E-mail: ______________________________________________ Affected Family: Relative/Professional/Other: Out of Country: ______$25.00 ______$30.00 ______$35.00 AFFECTED CHILD’S NAME(S) AND Enclosed membership payment: Enclosed donation: Total: DATE OF BIRTH MEMORIAL DATE $ ________ $ ________ $ ________ SEX SIBLINGS’ NAMES DIAGNOSIS/ MPS DISORDER Would you like your name to appear in our Parent Referral Directory? Yes ______ No ______ Initial consent:__________ Would you like to have your affected child’s name appear on the Birthday/Memorial page? Yes ______ No ______ If so, please fill in all information in the above chart, as you would like it to appear. I am willing to allow the Society to publish pictures of my living/deceased child(ren) for posters, advertising, booklets, brochures, and the MPS website. Yes ______ No ______ (Please send/email clear photos. We will return photos if requested.) Signed:______________________________________________ Date:_____________________ Please send information on MPS Diseases to the following professionals: Name:_______________________________________________________________ Address:_____________________________________________________________ IF YOU HAVE AN AFFECTED CHILD AND CANNOT AFFORD THE $25.00 MEMBERSHIP FEE, PLEASE INFORM THE OFFICE AND WE WILL SEND YOU COMPLIMENTARY NEWSLETTERS. The Canadian MPS Society is committed to providing support to fami- Please make cheques payable to: lies affected with MPS and related diseases, educating medical profesTHE CANADIAN MPS SOCIETY sionals and the general public about MPS, and funding research so that one day cures will be found for all types of MPS and related disPO Box 30034, RPO Parkgate eases. Members will receive: Four newsletters per year (Spring, Summer, Fall, Winter) Our Family Referral Directory Our Annual Report Access to our Family Assistance Program Advocacy support All new publications printed by the Society Invitations to attend family meetings and conferences Winter 2009 North Vancouver, BC V7H 2Y8 Please charge my credit card in the amount of $______________ Credit Card #________________________________________ Name on card ________________________________________ Expiry Date __________Signature________________________ Registered Charity # 12903 0409 RR0001 Page 33 FAMILY ASSISTANCE PROGRAM FUNDING APPLICATION Date:_________________ Name:________________________________________________________________________ Address:_____________________________________________________________________ _____________________________________________________________________________ Phone: ___________________________________ Email: ___________________________________ Name(s) of affected child(ren):___________________________________________________ Amount of funding requested: ______________ Please describe what the funds will be used for: ____________________________________ _____________________________________________________________________________ _____________________________________________________________________________ _____________________________________________________________________________ Will the funds being requested be used to pay for part of a larger project or piece of equipment? (eg. home renovations, wheelchair-accessible van, etc.) Yes________No_________ If you answered yes to the previous question: What is the estimated total cost of the project/equipment? _____________ Please list other funding agencies you have applied to for funding for this project/equipment, and funds received, if any: _______________________________________________________________________ _______________________________________________________________________ □ Estimate(s) included. (Please see guidelines for information on required estimates.) Signature______________________________________________Date___________________ Thank you for submitting your Family Assistance Program funding application. The Executive Director or a member of the Board of Directors will contact you as soon as possible to inform you of the Board’s decision regarding your application. Please visit www.mpssociety.ca or email kirsten@mpssociety.ca for complete Family Assistance Program guidelines. Page 34 The Connection The Canadian MPS Society’s Publications Canadian MPS Society booklets and merchandise can now also be ordered through our online store at www.mpssociety.ca NUMBER OF COPIES NAME OF BOOKLET PRICE PER COPY Family Resource Book - English or French* 4.00 Daily Living with MPS and Related Diseases 2.00 MPS I (Hurler/Scheie Diseases) - English or French * 2.00 MPS II (Hunter Syndrome) 2.00 MPS III (Sanfilippo Syndrome) 2.00 MPS IV (Morquio Syndrome) 2.00 MPS VI (Maroteaux-Lamy Syndrome) 1.00 Mucolipidosis II (I-Cell Disease) and III 1.00 Fucosidosis 1.00 Mannosidosis 1.00 Aspartylglucosaminuria 1.00 Mucolipidosis IV 1.00 Multiple Sulfphatase Deficiency 1.00 Tay-sachs & Sandhoff Disease 1.00 Hearing impairment in MPS Children 1.00 Is your child Having an Anaesthetic? 1.00 Bone Marrow Transplants in MPS Children 1.00 The Pattern of Inheritance 4.00 Choices – When your child is Dying - English or French* 7.00 Video—A Roll of the Dice 10.00 TOTAL PRICE *All booklets are in English with the exception of the Family Resource Book, MPS I Booklet & Choices. Please circle language. PLEASE ADD $2.50 FOR SHIPPING. (For 10 or more booklets add $5.00.) Name: __________________________________________________________________________________________________ Address: ________________________________________________________________________________________________ City:______________________________________________Province ________________Postal Code: ____________________ Telephone: ( _____) _________________ # of Booklets: _________________ Shipping & Handling: _________________ Send your order and cheque to: The Canadian MPS Society PO Box 30034, RPO Parkgate North Vancouver, BC V7H 2Y8 For payment by credit card, please call our head office at (604) 924-5130 or 1-800-667-1846. Winter 2009 Page 35 S MPS Society Logo Wear Indigo Sweatshirts $30.00 Jean Shirts $30.00 Indigo T-shirts $20.00 Children’s t-shirts $15.00 M L XL Plus $5.00 for shipping & handling (per item) Total Enclosed__________ Page 35 Season’s Greetings to all members of the Canadian MPS Society! On behalf of the board of directors and all of us at the Society, we wish you health and happiness in 2010 This year’s winner of our Holiday Art Contest is by Monika Nelis-Dupont, MPS I H/S, age 10. Her artwork has been featured on the Canadian MPS Society’s Holiday Greeting Cards for 2009. PO Box 30034, RPO Parkgate North Vancouver, BC V7H 2Y8 Tel: (604) 924-5130 / 1-800-667-1846 Fax: (604) 924-5131 www.mpssociety.ca